A Phase II study of Bcl-2 antisense (oblimersen sodium) combined with gemtuzumab ozogamicin in older patients with acute myeloid leukemia in first relapse (Q83858285)

From Wikidata
Jump to navigation Jump to search
scientific article published on 26 May 2006
edit
Language Label Description Also known as
English
A Phase II study of Bcl-2 antisense (oblimersen sodium) combined with gemtuzumab ozogamicin in older patients with acute myeloid leukemia in first relapse
scientific article published on 26 May 2006

    Statements

    title
    A Phase II study of Bcl-2 antisense (oblimersen sodium) combined with gemtuzumab ozogamicin in older patients with acute myeloid leukemia in first relapse (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    16730060
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16730060%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    28 January 2020
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q83858285&oldid=2213958325"